These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells]. Xinxin H; Meng Z; Guiyu Z Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733 [TBL] [Abstract][Full Text] [Related]
3. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer. Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway. Hou X; Zhao M; Wang T; Zhang G Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110 [TBL] [Abstract][Full Text] [Related]
5. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma. Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964 [TBL] [Abstract][Full Text] [Related]
6. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology. Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111 [TBL] [Abstract][Full Text] [Related]
7. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma. Lin YM; Velmurugan BK; Yeh YL; Tu CC; Ho TJ; Lai TY; Tsai CH; Tsai FJ; Tsai CH; Huang CY Oncol Rep; 2013 Dec; 30(6):3027-31. PubMed ID: 24126791 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913 [TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma. Hu K; Zhong G; He F Int J Gynecol Cancer; 2005; 15(3):537-41. PubMed ID: 15882182 [TBL] [Abstract][Full Text] [Related]
12. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium. Zhou XH; Teng XD; Song WY; Wu YJ Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050 [TBL] [Abstract][Full Text] [Related]
13. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells. Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074 [TBL] [Abstract][Full Text] [Related]
15. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha. Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells. Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma. Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792 [TBL] [Abstract][Full Text] [Related]
19. Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen. Ning C; Xie B; Zhang L; Li C; Shan W; Yang B; Luo X; Gu C; He Q; Jin H; Chen X; Zhang Z; Feng Y Cancer Res; 2016 Mar; 76(6):1354-66. PubMed ID: 26744532 [TBL] [Abstract][Full Text] [Related]
20. [Analysis different transcriptional factors in different phenotype endometrial cancer cells]. Sun PM; Wei LH; Zhao LJ; Liu N; Wang JL; Song YY; Chen XJ; Lin H Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):209-13. PubMed ID: 19570448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]